🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hepatic metastases are common in solid cancers (up to 30% of patients with ...
Status
Active Not Recruiting
Location
Centre Georges François Leclerc
Start Date
2020-01-20
Trial ID
NCT04242342
Treatments Being Tested
The MRI linac Unity is a major technological evolution in radiotherapy comb...
Status
Recruiting
Location
Hôpital Lyon Sud/ service de Radiothérapie Oncologie
Start Date
2024-01-08
Trial ID
NCT06041555
Treatments Being Tested
The Phase III study will include 174 patients with locally advanced orophar...
Status
Completed
Location
Clinique Claude Bernard
Start Date
2013-07
Trial ID
NCT01874587
Treatments Being Tested
Pancreatic cancer is on the rise, and is set to become the 2nd leading caus...
Status
Not Yet Recruiting
Location
Centre d'Oncologie du Pays-Basque
Start Date
2025-09
Trial ID
NCT07097064
Treatments Being Tested
The aim of this clinical trial is to evaluate the efficacy of adaptive pros...
Status
Recruiting
Location
Centre Eugène Marquis
Start Date
2026-03-02
Trial ID
NCT07189598
Standard treatment for oropharynx cancer is radiotherapy by intensity modul...
Status
Completed
Location
Clinique Claude Bernard
Start Date
2013-07-05
Trial ID
NCT05025618
This study is proposed to evaluate whether giving part of the chemotherapy ...
Status
Completed
Location
Hôpital de Gatineau
Start Date
2009-11
Trial ID
NCT01274962
Treatments Being Tested
This study evaluates whether adaptive stereotactic body radiotherapy (SBRT)...
Status
Recruiting
Location
Clinique Sainte Clotilde
Start Date
2025-11-18
Trial ID
NCT07344844
Treatments Being Tested
This study evaluates the effect of adaptative Intensity-Modulated Radiation...
Status
Completed
Location
Institut de Cancérologie de l'Ouest
Start Date
2017-04-05
Trial ID
NCT02937948
Treatments Being Tested